FibroGen (NASDAQ:FGEN) Posts Quarterly Earnings Results, Misses Estimates By $0.05 EPS
FibroGen (NASDAQ:FGEN – Get Rating) posted its earnings results on Monday. The biopharmaceutical company reported ($0.81) EPS for the quarter, missing the consensus estimate of ($0.76) by ($0.05), Briefing.com reports. The company had revenue of $36.16 million for the quarter, compared to the consensus estimate of $31.52 million. FibroGen had a negative net margin of […]